Evidence for Enhanced Efficacy of Passive Immunotherapy against Beta-Amyloid in CD33-Negative 5xFAD Mice

Passive immunotherapy is a very promising approach for the treatment of Alzheimer’s disease (AD). Among the different antibodies under development, those targeting post-translationally modified Aβ peptides might combine efficient reduction in beta-amyloid accompanied by lower sequestration in periph...

Descripción completa

Detalles Bibliográficos
Autores principales: Gnoth, Kathrin, Geissler, Stefanie, Feldhaus, Julia, Taudte, Nadine, Ilse, Victoria, Zürner, Sebastian, Greiser, Sebastian, Braumann, Ulf-Dietrich, Rahfeld, Jens-Ulrich, Cynis, Holger, Schilling, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945487/
https://www.ncbi.nlm.nih.gov/pubmed/35327591
http://dx.doi.org/10.3390/biom12030399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945487/
https://www.ncbi.nlm.nih.gov/pubmed/35327591
http://dx.doi.org/10.3390/biom12030399

Ejemplares similares